Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Journal of Biological Regulators and Homeostatic Agents|September 30, 2017
Clusterin serum level: how does it affect psoriatic patients?R Buquicchio, C Foti, F Loconsole, et al.Journal of Biological Regulators and Homeostatic Agents|October 10, 2008
Is there an association between antiphospholipid antibodies and psoriasis?N Cassano, R Buquicchio, V Ranieri, et al.Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 9, 2010
Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label studyN Cassano, R Mantegazza, S Battaglini, et al.International Journal of Immunopathology and Pharmacology|March 30, 2006
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)N Cassano, F Loconsole, A Galluccio, et al.Recenti Progressi in Medicina|September 1, 1989
Cell-mediated immune response in psoriasis and psoriatic arthritisM Ventura, M Colizzi, A Ottolenghi, et al.Recenti Progressi in Medicina|June 1, 1991
[Evaluation of D-dimer levels in obliterating arteriopathies]V Petruzzellis, M T Ventura, T Florio, et al.Journal of Biological Regulators and Homeostatic Agents|October 10, 2008
Efalizumab in moderate-to-severe plaque psoriasis: a retrospective case series analysis from clinical practiceN Cassano, V Mastrandrea, R Buquicchio, et al.International Journal of Immunopathology and Pharmacology|September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patientsN Cassano, A Puglisi Guerra, C Malara, et al.Journal of Biological Regulators and Homeostatic Agents|September 2, 2011
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic diseaseN Cassano, V Mastrandrea, M Principi, et al.International Journal of Immunopathology and Pharmacology|October 6, 2004
Infliximab monotherapy for refractory psoriasis: preliminary resultsN Cassano, F Loconsole, A Amoruso, et al.Pageof 5